HealthQuest Capital leads Series B round for Magnolia Medical
Seattle-based Magnolia Medical Technologies, a provider of blood fluid collections that improve the accuracy of in-vitro diagnostic test results, has raised $13.8 million in Series B funding. HealthQuest Capital led the round. In addition to the funding, Dr. Garheng Kong, founder and managing partner of HealthQuest Capital, has been added to Magnolia Medical's board.
13 July 2016•4 mins read
